Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.

Cattaneo F, Iaccio A, Guerra G, Montagnani S, Ammendola R.

Free Radic Biol Med. 2011 Sep 15;51(6):1126-36. doi: 10.1016/j.freeradbiomed.2011.05.040. Epub 2011 Jun 12.

PMID:
21708247
2.

FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast.

Iaccio A, Cattaneo F, Mauro M, Ammendola R.

Arch Biochem Biophys. 2009 Jan 1;481(1):94-100. doi: 10.1016/j.abb.2008.10.026. Epub 2008 Oct 26.

PMID:
18996352
3.

Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.

Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.

Mol Pharmacol. 2003 Sep;64(3):721-30.

4.
5.

WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A.

Cattaneo F, Parisi M, Ammendola R.

FEBS Lett. 2013 May 21;587(10):1536-42. doi: 10.1016/j.febslet.2013.03.036. Epub 2013 Apr 11.

6.

Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells.

Chowdhury AK, Watkins T, Parinandi NL, Saatian B, Kleinberg ME, Usatyuk PV, Natarajan V.

J Biol Chem. 2005 May 27;280(21):20700-11. Epub 2005 Mar 17.

7.

Differential activation of formyl peptide receptor-like 1 by peptide ligands.

Bae YS, Yi HJ, Lee HY, Jo EJ, Kim JI, Lee TG, Ye RD, Kwak JY, Ryu SH.

J Immunol. 2003 Dec 15;171(12):6807-13.

8.

Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.

Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, Kwak JY, Ryu SH.

J Immunol. 2004 Jul 1;173(1):607-14.

10.

Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl-leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts.

Ammendola R, Russo L, De Felice C, Esposito F, Russo T, Cimino F.

Free Radic Biol Med. 2004 Jan 15;36(2):189-200.

PMID:
14744631
11.

The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.

Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.

Biochem Pharmacol. 2007 Oct 1;74(7):1050-6. Epub 2007 Jul 7.

PMID:
17692291
13.

Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation.

El Zein N, D'Hondt S, Sariban E.

Cell Signal. 2010 Oct;22(10):1437-47. doi: 10.1016/j.cellsig.2010.05.012. Epub 2010 May 24.

PMID:
20566383
14.

Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1.

Björkman L, Karlsson J, Karlsson A, Rabiet MJ, Boulay F, Fu H, Bylund J, Dahlgren C.

J Leukoc Biol. 2008 Feb;83(2):245-53. Epub 2007 Nov 5.

PMID:
17984291
15.

A novel nonpeptide ligand for formyl peptide receptor-like 1.

Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, Ye RD.

Mol Pharmacol. 2004 Nov;66(5):1213-22. Epub 2004 Aug 12.

16.
17.
18.

Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.

Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS.

Lung Cancer. 2007 Apr;56(1):25-33. Epub 2006 Dec 15.

PMID:
17175059
19.
20.

Supplemental Content

Support Center